European Union - English - EMA (European Medicines Agency)

sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaccines - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4.2 and 5.1 in product information document).the use of this vaccine should be in accordance with official recommendations.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - concentrate for dispersion for injection - covid-19 mrna vaccine 0.5 mg/ml - covid-19 vaccines - comirnaty is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 virus, in individuals 12 years of age and older.

Israel - English - Ministry of Health

pfizer pharmaceuticals israel ltd - covid-19 mrna vaccine - concentrate for dispersion for injection - covid-19 mrna vaccine 0.1 mg/ml - covid-19 vaccines - for active immunization to prevent covid-19 caused by sars-cov-2 virus, in children aged 5 to 11 years.

Kenya - English - Pharmacy and Poisons Board

sars-cov-2, 19ncov-cdc-tan-hb02 strain… - injection - acceptance range for antigen content:… - covid-19 vaccines

Kenya - English - Pharmacy and Poisons Board

inactivated sars-cov-2 virus (19ncov-cdc-tan-hb02… - injection - (1) 0.5ml/syringe (each pre-filled syringe… - covid-19 vaccines

Kenya - English - Pharmacy and Poisons Board

messenger rna (mrna) (embedded in sm-102 lipid… - dispersion for injection - one dose (0.5 ml) contains 100 micrograms of… - covid-19 vaccines

Kenya - English - Pharmacy and Poisons Board

single-stranded, 5’-capped messenger rna (mrna)… - injection - 30 micrograms of covid-19 mrna vaccine (embedded… - covid-19 vaccines

Kenya - English - Pharmacy and Poisons Board

astraallen se151 85 sodertalje sweden - chimpanzee adenovirus encoding the sars-cov-2… - suspension for injection - not less than 2.5 x 10^8 infectious units (inf.u)… - covid-19 vaccines

European Union - English - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaccines - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4.2, 4.4 and 4.8).the use of dengvaxia should be in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein - hemorrhagic fever, ebola - vaccines - ervebo is indicated for active immunization of individuals 1 year of age or older to protect against ebola virus disease (evd) caused by zaire ebola virus.the use of ervebo should be in accordance with official recommendations.